Curcumin reduces prostaglandin E2, matrix metalloproteinase-3 and proteoglycan release in the secretome of interleukin 1β-treated articular cartilage

F1000Research

Volumn 2, Issue , 2013, Pages

  Mobasheri, Ali ^a,c,d,e   Clutterbuck, Abigail L ^a   Allaway, David ^b   Harris, Pat ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b WALTHAM CENTRE FOR PET NUTRITION   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d UNIVERSITY OF BRADFORD   (United Kingdom)

^e KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

CARPROFEN; CURCUMIN; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; PROTEOGLYCAN; STROMELYSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICATABOLIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CATABOLISM; CELL ASSAY; CELL DEATH; CHONDROPATHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE TECHNIQUE; CYTOTOXICITY; DISEASE MODEL; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; EXPLANT; IN VITRO STUDY; METACARPOPHALANGEAL JOINT; MONOLAYER CULTURE; NONHUMAN; OSTEOARTHRITIS; PROSTAGLANDIN RELEASE; PROTEIN SECRETION; WESTERN BLOTTING;

EID: 84898987744     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.2-147.v2     Document Type: Article

References (52)

1. Maiotti M Monteleone G Tarantino U: Correlation between osteoarthritic cartilage damage and levels of proteinases and proteinase inhibitors in synovial fluid from the knee joint. Arthroscopy. 2000;16(5):522-526. 10882449 10.1053/jars.2000.4632
2. Ahmed S Anuntiyo J Malemud CJ: Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review. Evid Based Complement Alternat Med. 2005;2(3):301-308. 16136208 10.1093/ecam/neh117 1193557
3. Elmali N Baysal O Harma A: Effects of resveratrol in inflammatory arthritis. Inflammation. 2007;30(1-2):1-6. 17115116 10.1007/s10753-006-9012-0
4. Gerhauser C Klimo K Heiss E: Mechanism-based in vitro screening of potential cancer chemopreventive agents. Mutat Res. 2003;523-524:163-172. 12628514 10.1016/S0027-5107(02)00332-9
5. Jobin C Bradham CA Russo MP: Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 1999;163(6):3474-3483. 10477620
6. Shakibaei M John T Schulze-Tanzil G: Suppression of NF-kappaB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem Pharmacol. 2007;73(9):1434-1445. 17291458 10.1016/j.bcp.2007.01.005
7. Clutterbuck AL Allaway D Harris P: Toxic effects of curcumin (diferuloylmethane) on equine articular chondrocytes and synoviocytes in vitro. Eur Cell Mater. 2008;16(Suppl. 3):43. Reference Source
8. Toegel S Wu SQ Piana C: Comparison between chondroprotective effects of glucosamine, curcumin, and diacerein in IL-1beta-stimulated C-28/I2 chondrocytes. Osteoarthritis Cartilage. 2008;16(10):1205-1212. 18321735 10.1016/j.joca.2008.01.013
9. Finger F Schorle C Zien A: Molecular phenotyping of human chondrocyte cell lines T/C-28a2, T/C-28a4, and C-28/I2. Arthritis Rheum. 2003;48(12):3395-3403. 14673991 10.1002/art.11341
10. Dvorak LD Cook JL Kreeger JM: Effects of carprofen and dexamethasone on canine chondrocytes in a three-dimensional culture model of osteoarthritis. Am J Vet Res. 2002;63(10):1363-1369. 12371761 10.2460/ajvr.2002.63.1363
11. Blanco FJ Ochs RL Schwarz H: Chondrocyte apoptosis induced by nitric oxide. Am J Pathol. 1995;146(1):75-85. 7856740 1870754
12. Farndale RW Sayers CA Barrett AJ: A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res. 1982;9(4):247-248. 6215207 10.3109/03008208209160269
13. Henrotin Y Priem F Mobasheri A: Curcumin: a new paradigm and therapeutic opportunity for the treatment of osteoarthritis: curcumin for osteoarthritis management. Springerplus. 2013;2(1):56. 23487030 10.1186/2193-1801-2-56 3591524
14. Mobasheri A Henrotin Y Biesalski HK: Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health. Int J Mol Sci. 2012;13(4):4202-4232. 22605974 10.3390/ijms13044202 3344210
15. Henrotin Y Clutterbuck AL Allaway D: Biological actions of curcumin on articular chondrocytes. Osteoarthritis Cartilage. 2010;18(2):141-149. 19836480 10.1016/j.joca.2009.10.002
16. Moon Y Glasgow WC Eling TE: Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways. J Pharmacol Exp Ther. 2005;315(2):788-795. 16081677 10.1124/jpet.105.084434
17. Woo JH Kim YH Choi YJ: Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis. 2003;24(7):1199-1208. 12807727 10.1093/carcin/bgg082
18. Csaki C Mobasheri A Shakibaei M: Synergistic chondroprotective effects of curcumin and resveratrol in human articular chondrocytes: inhibition of IL-1beta-induced NF-kappaB-mediated inflammation and apoptosis. Arthritis Res Ther. 2009;11(6):R165. 19889203 10.1186/ar2850 3003513
19. Garcia AM Frank EH Grimshaw PE: Contributions of fluid convection and electrical migration to transport in cartilage: relevance to loading. Arch Biochem Biophys. 1996;333(2):317-325. 8809069 10.1006/abbi.1996.0397
20. Cao L Lee V Adams ME: beta-Integrin-collagen interaction reduces chondrocyte apoptosis. Matrix Biol. 1999;18(4):343-355. 10517181 10.1016/S0945-053X(99)00027-X
21. Chu CR Izzo NJ Papas NE: In vitro exposure to 0.5% bupivacaine is cytotoxic to bovine articular chondrocytes. Arthroscopy. 2006;22(7):693-699. 16843803 10.1016/j.arthro.2006.05.006
22. Otsuki S Brinson DC Creighton L: The effect of glycosaminoglycan loss on chondrocyte viability: a study on porcine cartilage explants. Arthritis Rheum. 2008;58(4):1076-1085. 18383360 10.1002/art.23381
23. Khatib AM Siegfried G Messai H: Mechanism of inhibition of endothelin-1-stimulated proteoglycan and collagen synthesis in rat articular chondrocytes. Cytokine. 2002;17(5):254-261. 12027406 10.1006/cyto.2001.1001
24. Blanco FJ Lotz M: IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2. Exp Cell Res. 1995;218(1):319-325. 7537695 10.1006/excr.1995.1161
25. Murrell GA Jang D Williams RJ: Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun. 1995;206(1):15-21. 7529496 10.1006/bbrc.1995.1003
26. Brouet I Ohshima H: Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun. 1995;206(2):533-540. 7530002 10.1006/bbrc.1995.1076
27. Clutterbuck AL Mobasheri A Shakibaei M: Interleukin-1beta-induced extracellular matrix degradation and glycosaminoglycan release is inhibited by curcumin in an explant model of cartilage inflammation. Ann N Y Acad Sci. 2009;1171:428-435. 19723086 10.1111/j.1749-6632.2009.04687.x
28. Shinmei M Masuda K Kikuchi T: Production of cytokines by chondrocytes and its role in proteoglycan degradation. J Rheumatol Suppl. 1991;27:89-91. 2027138
29. Chubinskaya S Huch K Mikecz K: Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints. Lab Invest. 1996;74(1):232-240. 8569187
30. Okada Y Shinmei M Tanaka O: Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest. 1992;66(6):680-690. 1602738
31. Tung JT Fenton JI Arnold C: Recombinant equine interleukin-1beta induces putative mediators of articular cartilage degradation in equine chondrocytes. Can J Vet Res. 2002;66(1):19-25. 11858644 226977
32. Julovi SM Yasuda T Shimizu M: Inhibition of interleukin-1beta-stimulated production of matrix metalloproteinases by hyaluronan via CD44 in human articular cartilage. Arthritis Rheum. 2004;50(2):516-525. 14872494 10.1002/art.20004
33. Shiomi T Lemaitre V D'Armiento J: Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in non-neoplastic diseases. Pathol Int. 2010;60(7):477-496. 20594269 10.1111/j.1440-1827.2010.02547.x
34. Fosang AJ Neame PJ Hardingham TE: Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins. J Biol Chem. 1991;266(24):15579-15582. 1874716
35. Fosang AJ Last K Knauper V: Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem J. 1993;295(Pt 1):273-276. 8216228 1134849
36. Fosang AJ Last K Knauper V: Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett. 1996;380(1-2):17-20. 8603731 10.1016/0014-5793(95)01539-6
37. Schulze-Tanzil G Mobasheri A Sendzik J: Effects of curcumin (diferuloylmethane) on nuclear factor kappaB signaling in interleukin-1beta-stimulated chondrocytes. Ann N Y Acad Sci. 2004;1030:578-586. 15659840 10.1196/annals.1329.067
38. Mathy-Hartert M Jacquemond-Collet I Priem F: Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes. Inflamm Res. 2009;58(12):899-908. 19579007 10.1007/s00011-009-0063-1
39. Mitchell PG Magna HA Reeves LM: Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest. 1996;97(3):761-768. 8609233 10.1172/JCI118475 507114
40. Ohta S Imai K Yamashita K: Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage. Lab Invest. 1998;78(1):79-87. 9461124
41. Barksby HE Milner JM Patterson AM: Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis. Arthritis Rheum. 2006;54(10):3244-3253. 17009259 10.1002/art.22167
42. Jagetia GC Aggarwal BB: "Spicing up" of the immune system by curcumin. J Clin Immunol. 2007;27(1):19-35. 17211725 10.1007/s10875-006-9066-7
43. Handler N Jaeger W Puschacher H: Synthesis of novel curcumin analogues and their evaluation as selective cyclooxygenase-1 (COX-1) inhibitors. Chem Pharm Bull (Tokyo). 2007;55(1):64-71. 17202703 10.1248/cpb.55.64
44. Hong J Bose M Ju J: Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis. 2004;25(9):1671-1679. 15073046 10.1093/carcin/bgh165
45. Catley MC Chivers JE Cambridge LM: IL-1beta-dependent activation of NF-kappaB mediates PGE 2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase. FEBS Lett. 2003;547(1-3):75-79. 12860389 10.1016/S0014-5793(03)00672-0
46. Joe B Lokesh BR: Effect of curcumin and capsaicin on arachidonic acid metabolism and lysosomal enzyme secretion by rat peritoneal macrophages. Lipids. 1997;32(11):1173-1180. 9397403 10.1007/s11745-997-0151-8
47. Jin CY Lee JD Park C: Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia. Acta Pharmacol Sin. 2007;28(10):1645-1651. 17883952 10.1111/j.1745-7254.2007.00651.x
48. Gosset M Berenbaum F Levy A: Prostaglandin E2 synthesis in cartilage explants under compression: mPGES-1 is a mechanosensitive gene. Arthritis Res Ther. 2006;8(4):R135. 16872525 10.1186/ar2024 1779392
49. Patwari P Cook MN DiMicco MA: Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines. Arthritis Rheum. 2003;48(5):1292-1301. 12746902 10.1002/art.10892
50. Hui W Rowan AD Richards CD: Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum. 2003;48(12):3404-3418. 14673992 10.1002/art.11333
51. Sharma RA McLelland HR Hill KA: Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res. 2001;7(7):1894-1900. 11448902
52. Bisht S Feldmann G Soni S: Polymeric nanoparticle-encapsulated curcumin ("nanocurcumin"): a novel strategy for human cancer therapy. J Nanobiotechnology. 2007;5:3. 17439648 10.1186/1477-3155-5-3 1868037